Vivos Therapeutics Reports Third Quarter 2026 Financial Results
Vivos Therapeutics announced its financial results for the third quarter of 2026, reporting a 24% quarter-over-quarter revenue increase to $6.4 million and an 18% year-over-year improvement in operating loss.